CN1814618A - Japanese schistosome metalloproteuse minic peptide and its screening method and use - Google Patents
Japanese schistosome metalloproteuse minic peptide and its screening method and use Download PDFInfo
- Publication number
- CN1814618A CN1814618A CN 200510031216 CN200510031216A CN1814618A CN 1814618 A CN1814618 A CN 1814618A CN 200510031216 CN200510031216 CN 200510031216 CN 200510031216 A CN200510031216 A CN 200510031216A CN 1814618 A CN1814618 A CN 1814618A
- Authority
- CN
- China
- Prior art keywords
- phage
- leu
- pro
- screening
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
This invention provides an analog polymorphism amino-acid series of two kinds of Japanese blood fluke metallic protease and its protective immune action to the blood fluke, which utilizes Japanese blood fluke 85kDa metallic protease to sieve phage dodecapeptide library and utilizes phage ELISA, DNA sequencing. Western blot and enzyme activity neutralization test to analyze the selected clons and utilizes an animal experiment to test its immune protection effect, finally, the 10 clons randomly selected are all positive verified by ELISA, five different amino acid serieses are got after test and phage expressing the serieses to clone immune kunming plant mice, in which, two clones can be induced with obvious vermin reduction rate: 31.0% and 31.8% and ovum reduction rate: 52.6% and 54.9% separately, which lays a foundation for researching new Japanese blood fluke vaccines.
Description
Technical field
The present invention relates to two kinds of Japanese schistosome metalloproteuse minic peptides and screening method thereof and the application aspect the anti schistosoma challenge infection, belong to biological technical field.
Background technology
Schistosomicide is that a kind of people beast of serious harm human health suffers from parasitosis altogether, is widely current in the Asia, Africa and Hispanic 74 countries and regions, has 200,000,000 people to be infected approximately, the infected threat of 600,000,000 people.Having five kinds of schistosomicide can infected person and cause the human body schistosomicide, be schistosomiasis japanica at China's popular, this disease be popular in the Yangtze valley and on the south 12 provinces, cities and autonomous regions, bring serious harm for people's healthy and social Economic development.
People are exploring the effective way of control and elimination schistosoma disease always for a long time.Although the multiple prophylactico-therapeutic measures that comprises chemotherapy is arranged at present, but because killing oncomelania and control contagium difficulty are very big, schistosomicide remains a serious public health problem that needs to be resolved hurrily so far, to fundamentally control the popular of schistosomicide, must develop the schistosomicide vaccine, because in the middle of the historical progress of human and disease fight, vaccine is a magic weapon that control disease is propagated, for human beings'health has been made huge contribution always.
Along with the development of biological chemistry and Protocols in Molecular Biology, the increasing effective antigen of schistosomicide is separated, and they can induce certain immune protective efficiency in various animal models.These antigens are mainly albumen and comprise enzyme or glycoprotein, have at present severally to be thought the blood fluke vaccine candidate antigens by WHO.Along with the appearance of gene recombination technology, people recombinate to japonicum gene, express with intestinal bacteria or yeast etc., have developed the japonicum gene engineered vaccine to solve the insufficient problem in source of native protein.Along with immunologic development, immunology theory deepening continuously on molecular level it has been recognized that effective vaccine reaction is by immunogenic antigen decision a small bundle of straw, etc. for silkworms to spin cocoons on is arranged, and just epitope causes.Therefore utilize and have strong immunogenic schistosome antigen epi-position and develop the important channel that blood fluke vaccine has become the blood fluke vaccine development.
Extensively exist various proteolytic enzyme in the schistosomicide body, they played an important role in bilharzial each etap.In these proteolytic enzyme, metalloprotease has special effect, degrades the function that this general proteolytic enzyme had except having catalytic proteins, and it is also to schistosomicide invasion host with produce immune evasion material impact is arranged.Therefore, metalloprotease may be an ideal immunity target.
Proteic epitope can be analyzed and determine to phage random storehouse peptide technology not only, and the mimic epitopes that obtains do not need adjuvant can produce immunne response by inducing mouse yet, therefore, enjoys favor in new generation vaccine research.The present invention utilizes anti-metalloprotease serum screening phage random dodecapeptide storehouse to analyze the binding specificity of anti-metalloprotease serum IgG and metalloprotease epitope, the small peptide of separation simulation metalloprotease epitope, observe these small peptides and in mouse, induce the immune effect of protection against Schistosoma japonicum infection, lay the foundation for developing novel Japanese blood fluke vaccine.
Summary of the invention
The screening method that the object of the present invention is to provide two kinds of Japanese schistosome metalloproteuse minic peptides and a kind of Japanese schistosome metalloproteuse minic peptide is provided.
Another object of the present invention is to provide these two kinds of Japanese schistosome metalloproteuse minic peptides at immanoprotection action to the Schistosoma japonicum challenge infection.
Two kinds of Japanese schistosome metalloproteuse minic peptides of the present invention have following aminoacid sequence respectively
Ser-Asn-Pro-Pro-Gly-Met-Ala-Leu-Ser-Ala-Pro-Pro
And Ile-Thr-Ser-His-Thr-Gly-Yyr-Leu-Gln-Leu-Arg-Leu
Screening method of the present invention is: with SDS-PAGE separating metal proteolytic enzyme from the Schistosoma japonicum vomitus, with the gel immune mouse that contains the 85kDa metalloprotease, after three immunity, measure antibody titers and collect serum, slightly carry IgG with the saturated ammonium sulphate fractionation precipitation, the phage that the specificity bonding force is arranged with screening and IgG is shaken slowly in 37 ℃ in the original peptide storehouse that adds dilution in IgG wraps by plate; Unconjugated phage is removed in washing; Use glycine-hydrochloride buffer (pH2.2) room temperature wash-out again, collect elutriant and measure phage titre, the single phage clone of random choose joins in the ER2738 bacterium liquid, after 37 ℃ of shaking culture with the TBS phage that suspends, with the initiator of this suspension phage as programmed screening, carry out the affine screening of three-wheel altogether, obtain the phage polypeptide strong with the IgG binding specificity, that avidity is high; With in phage E LISA, dna sequencing, Westernblot, the enzymic activity and method such as experiment the clone of three-wheel screening back institute picking is analyzed, and measure its immune protective effect with experimentation on animals.
Japanese schistosome metalloproteuse minic peptide of the present invention can be applicable to schistosomicide challenge infection aspect.
Japanese schistosome metalloproteuse minic peptide provided by the invention has the protective immunity effect to Schistosoma japonicum, promptly is respectively with aminoacid sequence
Ser-Asn-Pro-Pro-Gly-Met-Ala-Leu-Ser-Ala-Pro-Pro
With two kinds of phage clone immunity kunming mices of Ile-Thr-Ser-His-Thr-Gly-Yyr-Leu-Gln-Leu-Arg-Leu, can induce tangible worm reduction rate (being respectively 31.0% and 31.8%) and egg reduction rate (being respectively 52.6% and 54.9%).
By screening to metalloproteuse minic peptide, overcome by natural way and can't obtain or the shortcoming of the metalloprotease epitope that is difficult to obtain, make and obtain effective schistosome antigen in a large number and become possibility, and the polypeptide structure that is obtained is clear, it is clear to form, for the synthetic polypeptide vaccine is laid a good foundation.
Description of drawings
The evaluation figure of the positive phage clone of Fig. 1
Fig. 2 is that the Western bolt of No. 2 and No. 3 phage clones analyzes
Be followed successively by from left to right: M13, No. 2 clone, No. 3 clone, Marker
Fig. 3 is for being the metal proteinase activity electrophoretic analysis figure of substrate with the gelatin
C: normal control group, Incubating Solution are the Tris-HCl damping fluid of 0.1M pH9.0;
2: the gel of hatching with No. 2 phage immune serums;
3: the gel of hatching with No. 3 phage immune serums;
E:EDTA, inhibitors of metalloproteinase, the EDTA of adding 1.0mM in the Incubating Solution;
S: the gel of hatching with the metalloprotease immune serum;
M13: the gel of hatching with the M13 immune serum.
Embodiment
1, main raw and source thereof:
(1) phage random dodecapeptide storehouse (Ph.D-12
TMPhage Display Peptide Library contains 1.5 * 10
13Pfu/ml) and host bacterium ER2738 be New England Bioexperiment institute (New England BiolabsInc.) product.
(2) the anti-M13 antibody (HRP-M13Ab) of horseradish peroxidase-labeled is available from Pharmcia company, and the sheep anti-mouse igg of horseradish peroxidase-labeled is a Promega company product.
(3) sodium lauryl sulphate is the import packing of Serva company, methylene diacrylamide is the import packing of Fluka company, it is New England Bioexperiment institute (New England Biolabs Inc.) product that albumen Marker is dyed in the import packing of acrylamide Amresco company, standard molecular weight in advance;
(4) Freund's complete adjuvant is a U.S. Sigma company product; Electrophoresis apparatus is a U.S. Bio-Rad company product, and the E960 microplate reader is an ERMC company product.
(5) laboratory animal and cercaria be used to the escape positive oncomelania of putting cercaria is bought from Jiangsu Province's preventing and treating verminosis institute, and female kunming mice is provided by the laboratory animal department of the Chinese Academy of Sciences of Central South University
(6) preparation of EDTA storage liquid dissolving 2.92 gram EDTA are in 10ml distilled water, and adjust pH to 8.0,1ml divide device-20 ℃.During use, be diluted to working concentration.
(7) table model high speed centrifuge, low-temperature and high-speed whizzer are Hunan Instrument General Factory's product.Other reagent is homemade analytical pure.
2, method and result
(1) the affine screening in thalline peptide storehouse
With SDS-PAGE separating metal proteolytic enzyme from the Schistosoma japonicum vomitus.With the gel immune mouse that contains the 85kDa metalloprotease, measure antibody titers and collect serum through three immunity backs, with the saturated ammonium sulphate fractionation precipitation IgG that slightly purifies, mensuration concentration.Coating buffer (the 0.1MNaHCO that contains 10 μ g IgG with 100 μ l
3, pH8.5) wrapper sheet is crossed liquid in 4 ℃ of wet boxes, and 5% skimmed milk (be dissolved in TBS[50mMTris, 150mMNaCl, pH7.5]) room temperature sealing 2h, the former peptide storehouse that adds 100 μ l dilution then (contains 10
11Individual plaque-forming unit) shakes 1h slowly in 37 ℃.With TBS-T (TBS that contains 0.5%V/V Tween-20) washing 8 times, to remove unconjugated phage.Use the every hole of glycine-hydrochloride buffer (pH2.2) the 100 μ l room temperature wash-outs 8 minutes of 0.2M again.Every hole adds 15 μ l neutralizers, and (1MTris-HCl pH9.1) after the neutralization, collects elutriant and measures phage titre.The single phage clone of random choose joined be cultured to OD
595In the ER2738 bacterium liquid of ≈ 0.5, behind 37 ℃ of shaking culture 4.5h 10, the centrifugal 15min of 000rpm collects supernatant, and (20%W/V PEG8000 is 2.5MNaCl) more than 4 ℃ of precipitation 2h to add the PEG/NaCl of 1/6 volume.Room temperature 10, the centrifugal 15min of 000rpm precipitation phage removes supernatant, with 1ml TBS suspension phage, put 4 ℃ standby.This suspension phage is carried out the screening of next round as the initiator of programmed screening, carry out the affine screening of three-wheel altogether.After the three-wheel screening, specific phage has obtained nearly 700 times enrichment.The titre of first round elutriant is 2.6 * 10
3Pfu/ml reaches 1.8 * 10 during to third round
6Pfu/ml (table 1)
The concentration effect of each wheel screening pnagus medius of table 1
The screening wheel number | The phage titre (pfu/ml) that adds | The phage titre of wash-out (pfu/ml) |
1 2 3 | 2×10 11 2×10 11 2×10 11 | 2.6×10 3 4.5×10 5 1.8×10 6 |
(2) thalline ELISA identifies positive colony
By ELISA batten (10 μ g/ hole), 4 ℃ are spent the night with metalloprotease immune serum IgG bag, 5% skimmed milk room temperature sealing 2h.Every hole adds 10
12Phage particle, room temperature is placed 2h.Wash the anti-M13 antibody that adds the HRP mark after 3 times with TBS-T, the TMB colour developing, 595nm measures absorbancy.Detected 10 with phage E LISA and paved the single phage clone of random choose the plate and the binding specificity of IgG antibody from the third round elutriant, with original peptide storehouse as negative control (NC).When OD value during more than or equal to the negative control twice, be judged to phage and combine with IgG antibody generation specificity, promptly be accredited as the positive.The result shows that the OD value of the single phage clone of 10 random chooses is compared with negative control, all greater than 2.0, all is positive colony
(Fig. 1)
(3) mensuration of insertion small peptide aminoacid sequence in the thalline
Extract phage single-chain DNA, with-96
111The phage sequencing primer: 5 '-
HOCCC TCA TAG TTAGCG TAA CG-3 ' checks order through the ABI100 automatic sequencer.Institute's calling sequence Expasy software analysis.Through dna sequence analysis, derive following 5 kinds of different aminoacid sequences to 10 positive phage clones
1.acg tcg ttt ggt agt atg ctt agt aag tgg cag aag
Thr-Ser-Fhe-Gly-Ser-Met-Leu-Ser-Lys-Trp-Gln-Lys
2.agt aat cct ccg ggg atg gct ctt tcg gct ccg cct
Ser-Asn-Pro-Pro-Gly-Met-Ala-Leu-Ser-Ala-Pro-Pro
3.att acg tcg cat acg ggg tat ctg cag ctt cgt ttg
Ile-Thr-Ser-His-Thr-Gly-Tyr-Leu-Gln-Leu-Arg-Leu
4.act ctt gct cat act agt cag att ggg ctt acg gct
Thr-Leu-Ala-His-Thr-Ser-Gln-Ile-Gly-Leu-Thr-Ala
5.atg gag gct tct cat acg cat gcg cgt ccg gcg cct
Met-Glu-Ala-Ser-His-Thr-His-Ala-Arg-Pro-Ala-Pro
(4) immune protective of Schistosoma japonicum challenge infection (animal immune experiment)
70 4 age in week kunming mice be divided into 7 groups at random, wherein inject five kinds of not homotactic phages respectively subcutaneous for 5 groups.Injected dose is 10
12Phage particle divides 3 injections, and control group is injected original peptide storehouse or TBS.Immunity three times.Immunity back two all every mouse infect 40 ± 1 of cercarias through skin of abdomen for the third time.Infect and cutd open adult extremely in back 42 days, calculate worm lotus and every gram liver ovum number (table 2).Statistical software carries out statistical study with the SPSS8.0 edition data.Data are expressed as mean+SD.When P≤0.05, thinking has significance.
The worm reduction rate of each group after the table 2-1 immunity
Group | Number of mice | Obtain borer population | Worm reduction rate | P |
12345 original peptide storehouse TBS | 10 10 10 10 10 10 10 | 23.6±1.6733 18.2±1.9235 18.0±1.4142 25.2±1.7889 24.2±2.2804 24.4±1.8166 26.4±1.9494 | 10.6 31.0 31.8 4.5 8.3 7.5 - | 0.055 0.001 * 0.001 * 0.48 0.073 0.318 - |
*There is significance P value≤0.05
The liver egg reduction rate of each group after the table 2-2 immunity
Group | Number of mice | Obtain borer population | Egg reduction rate | P |
12345 original peptide storehouse TBS | 10 10 10 10 10 10 10 | 99.36±7.28 57.75±3.62 54.94±3.64 106.3±3.84 102.4±2.35 108.8±3.46 121.86±3.47 | 18.5 52.6 54.9. 12.8 16.0 10.7 - | 0.009 * 0.001 * 0.001 * 0.145 0.055 0.200 - |
*There is significance P value≤0.05
Prove that from the animal immunization experiment No. 2 and No. 3 phage clones can be induced and be produced significant worm reduction rate (being respectively 31% and 31.8%) and higher egg reduction rate (reaching 52.6% and 54.9% respectively).
(5) immunoblotting assay
To (contain 10 through the phage clone after the amplification
12Phage particle) mix with the SDS sample-loading buffer, put boil 3min in the boiling water after, under non-reduced condition, carry out 10% SDS-PAGE electrophoresis and be transferred on the nitrocellulose membrane.Skim-milk with 5% is membrane closure 2h, PBS-T rinsing 3 times.With the metalloprotease immune serum is one anti-, and the sheep anti-mouse igg of HRP mark is two anti-, the DAB colour developing.The result shows, No. 2 and No. 3 phage clones are through the SDS-PAGE electrophoretic separation and after being transferred to nitrocellulose filter, it contains the gene III albumen that inserts small peptide can band occur at the 67kDa place, and wild-type M13 be unrecognized by schistosoma japonicum infection mice serum (IMS) identification.The result shows, No. 2 and No. 3 clones have good antigenicity (Fig. 2).
(6) with the gelatin be the metal proteinase activity analysis of substrate
Collect the Schistosoma japonicum vomitus, separate the 85kDa metalloprotease.Preparation contains 10% SDS-PAGE separation gel of 0.1% gelatin, and concentrated glue is that the 3.9%. vomitus mixes with the non-reduced sample buffer that does not add DTT afterwards without boiling the sample electrophoresis, and deposition condition is 4 ℃, constant current 18mA.After electrophoresis finished, the TritonX-100 100ml detergent gel with 2.5% 10 minutes was washed 3 times, to remove the SDS in the gel.With the washing of the Tris-HCl damping fluid of 0.1M pH9.0 after 5 minutes, gel vertically is cut into 6 little and carry out mark.Article one, place the Tris-HCl damping fluid overnight incubation of 0.1M pH9.0, overnight incubation in the damping fluid of putting 0.1M pH9.0Tris-HCl+1.0mM EDTA.Other 4 in being put into 0.1M pH9.0Tris-HCl damping fluid before, earlier hatch 2h with No. 2, No. 3, M13 phage immune serum and metalloprotease immune serum (dilution in 1: 50) in 37 ℃ respectively.Coomassie brilliant blue with 0.1% (0.1% Coomassie brilliant blue (the 0.1g Coomassie brilliant blue is dissolved in methyl alcohol: acetic acid: water is in 30: 10: 60 the solution, filters and preserves) dyeing 2h, after the decolouring, observations (Fig. 3)
The result shows, behind No. 2 and No. 3 phage immune mouses, the antibody that is produced is the same with the metalloprotease immune serum have in the effect of 85kDa metal proteinase activity.Among Fig. 32,3 and S (metalloprotease immune serum) bar gel show, the 85kDa metalloprotease respectively in No. 2, No. 3 phage immune serums or metalloprotease immune serum and after, lose the ability of gelatin hydrolysate, thereby the hydrolysis band can not appear, and the M13 immune serum can not in and the 85kDa MMP activities, hydrolysis band (M13 among Fig. 3) appears.The result shows, No. 2 and No. 3 phage small peptides have the immunogen characteristic of 85kDa metalloprotease epi-position.
Sequence table
<110〉easy Singapore dollar, Ceng Xianfang
<120〉Japanese schistosome metalloproteuse minic peptide and screening method thereof and application
<160>10
<210>1
<211>36
<212>DNA
<213〉phage (Phage)
<220>
<400>1
acg tcg ttt ggt agt atg ctt agt aag tgg cag aag 36
Thr Ser Fhe Gly Ser Met Leu Ser Lys Trp Gln Lys
1 5 10
<210>2
<211>36
<212>DNA
<213〉phage (Phage)
<220>
<400>2
agt aat cct ccg ggg atg gct ctt tcg gct ccg cct 36
Ser Asn Pro Pro Gly Met Ala Leu Ser Ala Pro Pro
1 5 10
<210>3
<211>36
<212>DNA
<213〉phage (Phage)
<220>
<400>3
att acg tcg cat acg ggg tat ctg cag ctt cgt ttg 36
Ile Thr Ser His Thr Gly Tyr Leu Gln Leu Arg Leu
1 5 10
<210>4
<211>36
<212>DNA
<213〉phage (Phage)
<220>
<400>4
act ctt gct cat act agt cag att ggg ctt acg gct 36
Thr Leu Ala His Thr Ser Gln Ile Gly Leu Thr Ala
1 5 10
<210>5
<211>36
<212>DNA
<213〉phage (Phage)
<220>
<400>5
atg gag gct tct cat acg cat gcg cgt ecg gcg cct 36
Met Glu Ala Ser His Thr His Ala Arg Pro Ala Pro
1 5 10
<210>6
<211>12
<212>PRT
<213〉phage (Phage)
<220>
<400>6
Thr Ser Fhe Gly Ser Met Leu Ser Lys Trp Gln Lys
1 5 10
<210>7
<211>12
<212>PRT
<213〉phage (Phage)
<220>
<400>7
Ser Asn Pro Pro Gly Met Ala Leu Ser Ala Pro Pro
1 5 10
<210>8
<211>12
<212>PRT
<213〉phage (Phage)
<220>
<400>8
Ile Thr Ser His Thr Gly Tyr Leu Gln Leu Arg Leu
1 5 10
<210>9
<211>12
<212>PRT
<213〉phage (Phage)
<220>
<400>9
Thr Leu Ala His Thr Ser Gln Ile Gly Leu Thr Ala
1 5 10
<210>10
<211>12
<212>PRT
<213〉phage (Phage)
<220>
<400>10
Met Glu Ala Ser His Thr His Ala Arg Pro Ala Pro
1 5 10
Claims (3)
1, two kinds of Japanese schistosome metalloproteuse minic peptides, its amino acid series is respectively
Ser-Asn-Pro-Pro-Gly-Met-Ala-Leu-Ser-Ala-Pro-Pro
And Ile-Thr-Ser-His-Thr-Gly-Yyr-Leu-Gln-Leu-Arg-Leu.
2, the screening method of the described Japanese schistosome metalloproteuse minic peptide of claim 1: with SDS-PAGE separating metal proteolytic enzyme from the Schistosoma japonicum vomitus, with the gel immune mouse that contains the 85kDa metalloprotease, after three immunity, measure antibody titers and collect serum, slightly carry IgG with the saturated ammonium sulphate fractionation precipitation, the original peptide storehouse that in IgG wraps by plate, adds dilution, slowly shake the phage that the specificity bonding force is arranged with screening and IgG in 37 ℃, unconjugated phage is removed in washing, use glycine-hydrochloride buffer room temperature wash-out under pH 2.2 conditions again, collect elutriant and measure phage titre, the single phage clone of random choose joins in the ER2738 bacterium liquid, after 37 ℃ of shaking culture with the TBS phage that suspends, with the initiator of this suspension phage as programmed screening, carry out the affine screening of three-wheel altogether, obtain with the IgG binding specificity strong, the phage polypeptide that avidity is high.With in phage E LISA, dna sequencing, Western blot, the enzymic activity and method such as experiment the clone of three-wheel screening back institute picking is analyzed, and measure its immune protective effect with experimentation on animals.
3, the application of the described Japanese schistosome metalloproteuse minic peptide of claim 1 aspect the schistosomicide challenge infection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510031216 CN1814618A (en) | 2005-01-31 | 2005-01-31 | Japanese schistosome metalloproteuse minic peptide and its screening method and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510031216 CN1814618A (en) | 2005-01-31 | 2005-01-31 | Japanese schistosome metalloproteuse minic peptide and its screening method and use |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1814618A true CN1814618A (en) | 2006-08-09 |
Family
ID=36906992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510031216 Pending CN1814618A (en) | 2005-01-31 | 2005-01-31 | Japanese schistosome metalloproteuse minic peptide and its screening method and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1814618A (en) |
-
2005
- 2005-01-31 CN CN 200510031216 patent/CN1814618A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Smith et al. | Developments and hurdles in generating vaccines for controlling helminth parasites of grazing ruminants | |
CN1062605C (en) | Escherichia coli vaccine | |
TWI357906B (en) | Neutralizing epitope-based growth enhancing vaccin | |
Augustine | Cell: sporozoite interactions and invasion by apicomplexan parasites of the genus Eimeria | |
Xu et al. | A effective DNA vaccine against diverse genotype J infectious hematopoietic necrosis virus strains prevalent in China | |
CN1020857C (en) | Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses | |
CN109182380A (en) | The preparation method and application of the swine fever E2 subunit vaccine of baculovirus expression | |
CN103596971B (en) | Antigen immunogenicity is adjusted by the epi-position of NKT cell recognition by deleting | |
CN1345375A (en) | Streptococcus pneumoniae antigens | |
CN1054772A (en) | Synthetic polypeptide | |
CN103517917B (en) | Antigen immunogenicity is adjusted by the epi-position of NKT cell recognition by adding | |
CN1059471A (en) | Heamophilus paragallinarum vaccine | |
CN1230195A (en) | immune-directed therapy | |
CN1438896A (en) | Vaccine comprising a tick cement protein | |
CN1814618A (en) | Japanese schistosome metalloproteuse minic peptide and its screening method and use | |
CN107970444A (en) | Composite adjuvant and the vaccine containing the composite adjuvant | |
CN103243105B (en) | A kind of Trichina recombinant protein and application | |
CN1194008C (en) | Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof | |
CN1216075C (en) | Hepatitis C virus high change region 1 synthetic peptide and its use | |
CN103275182A (en) | CD8+T cell dominant epitopes based on toxoplasmagondii bradyzoite antigens | |
CN102643336A (en) | Avian chlamydophila psittaci outer membrane protein N-PmpD, preparation method and application | |
CN103131719B (en) | Taenia multiceps enolase TmENO recombinant protein with immunizing protection | |
CN1438238A (en) | Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof | |
CN1063109A (en) | Improvement to hormone and associated materials | |
CN1796416A (en) | Immunoglobulin for anti virus of poultry influenza, preparation method and preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |